Related references
Note: Only part of the references are listed.The Economic Conundrum for Antibacterial Drugs
David M. Shlaes
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2020)
Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study
Nanshan Chen et al.
LANCET (2020)
Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study
Fei Zhou et al.
LANCET (2020)
Antimicrobial use, drug-resistant infections and COVID-19
Timothy M. Rawson et al.
NATURE REVIEWS MICROBIOLOGY (2020)
Estimating the Treatment of Carbapenem-Resistant Enterobacteriaceae Infections in the United States Using Antibiotic Prescription Data
Cornelius J. Clancy et al.
OPEN FORUM INFECTIOUS DISEASES (2019)
Estimating the Size of the US Market for New Antibiotics with Activity against Carbapenem-Resistant Enterobacteriaceae
Cornelius J. Clancy et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2019)
Innovation in the pharmaceutical industry: New estimates of R&D costs
Joseph A. DiMasi et al.
JOURNAL OF HEALTH ECONOMICS (2016)
Share Paper
